Skip to content
Brilliant Blue Biosciences logoBrilliant BlueBiosciences
Articles

Papers, explained in our own words

Every entry summarises what the study set out to test, what it found and why it changes how we design delivery systems. Browse research and reviews or search the collection.

586 articles

Showing 1–1 of 1 articles · Keyword: Interleukin-11 receptor alpha-1 Clear keyword

International journal of pharmaceutics2026ResearchNon-viral Gene DeliveryDrug Delivery

1. Disulfide bond-modified ionizable lipids for co-delivery of siRNA and carbon dots in the treatment of acute liver injury

Chu R, Shen Z, Pan T, Gao Q, Wang Z, He J

Acute liver injury (ALI) is a severe clinical condition characterized by excessive oxidative stress and inflammatory responses, for which effective targeted therapeutic strategies remain limited. In this study, a redox-responsive ionizable lipid (Lipid S) was designed by incorporating a disulfide bond into its…

Read the article
Articles | Brilliant Blue Biosciences